Literature DB >> 9817484

Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy.

K S Dujardin1, C Tei, T C Yeo, D O Hodge, A Rossi, J B Seward.   

Abstract

This study sought to investigate, in patients with idiopathic-dilated cardiomyopathy, the clinical and prognostic value of a Doppler-derived index of myocardial function that combines systolic and diastolic time intervals of the left heart cycle. The Doppler index was measured in 75 patients (aged 61 +/- 13 years; 45 men and 30 women) in sinus rhythm and 75 age- and sex-matched controls. Ejection time was measured from the left ventricular outflow Doppler signal. The sum of isovolumic times was obtained by subtracting the ejection time from the interval between cessation and onset of mitral inflow measured from the mitral inflow velocity profile. The index was the sum of isovolumic times divided by ejection time. The values of the Doppler index in patients with idiopathic-dilated cardiomyopathy (0.85 +/- 0.32) were significantly higher than values in controls (0.37 +/- 0.08, p < 0.001). During follow-up of 5 years, 1 patient underwent cardiac transplantation and 36 patients died, 29 of cardiac, 5 of noncardiac, and 2 of unknown causes. Univariate analysis demonstrated that the Doppler index (chi-square = 18.3, p < 0.001), ejection fraction (chi-square = 15.2, p <0.001), symptom status (chi-square = 9.2, p = 0.002), and mitral deceleration time (chi-square = 5.2, p = 0.02) were significant predictors of outcome. However, multivariate stepwise analysis of these variables showed that the Doppler index (chi-square = 10.7, p = 0.001) and ejection fraction (chi-square = 6.7, p = 0.01) were the most significant independent predictors of outcome. The Doppler index reflects disease severity and has incremental prognostic value in dilated cardiomyopathy. Ease of use, nongeometric dependency, excellent separation of clinical groups, and a strong relation to outcome enhance its appeal.

Entities:  

Mesh:

Year:  1998        PMID: 9817484     DOI: 10.1016/s0002-9149(98)00559-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  76 in total

1.  Tei-index in symptomatic patients with primary and secondary mitral regurgitation.

Authors:  Christian Bruch; Axel Schmermund; Nikolaos Dagres; Marc Katz; Thomas Bartel; Raimund Erbel
Journal:  Int J Cardiovasc Imaging       Date:  2002-04       Impact factor: 2.357

2.  Occult left ventricular dysfunction diagnosed by myocardial performance index in patients with limb girdle muscle dystrophy: A case control study.

Authors:  Rajashekar R Gurrala; Venkata Mb Alla; Wilbert S Aronow; Jai S Shankar; Meena K Angamutta; Krishna Lanka; Sundaram Challa; Chandra K Nair
Journal:  Int J Angiol       Date:  2007

Review 3.  Time intervals and myocardial performance index by tissue Doppler imaging.

Authors:  Michele Correale; Antonio Totaro; Riccardo Ieva; Natale Daniele Brunetti; Matteo Di Biase
Journal:  Intern Emerg Med       Date:  2010-10-14       Impact factor: 3.397

Review 4.  Echocardiographic assessment of left ventricular systolic function: from ejection fraction to torsion.

Authors:  Matteo Cameli; Sergio Mondillo; Marco Solari; Francesca Maria Righini; Valentina Andrei; Carla Contaldi; Eugenia De Marco; Michele Di Mauro; Roberta Esposito; Sabina Gallina; Roberta Montisci; Andrea Rossi; Maurizio Galderisi; Stefano Nistri; Eustachio Agricola; Donato Mele
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

5.  Myocardial Performance Index in Childhood Onset Essential Hypertension and White Coat Hypertension.

Authors:  Monesha Gupta-Malhotra; Rabih K Hamzeh; Tim Poffenbarger; Karen McNiece-Redwine; Syed Shahrukh Hashmi
Journal:  Am J Hypertens       Date:  2015-08-12       Impact factor: 2.689

6.  Myocardial performance index suggests optimal fluid loss during hemodialysis.

Authors:  Elektra S Papadopoulou; Savvas T Toumanidis; George Tsirpanlis; Chrisanthi O Trika; Garyfalia Kalatzopoulou; Spyridon D Moulopoulos
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

7.  Effect of preload and heart rate on the doppler and tissue doppler-derived myocardial performance index.

Authors:  Kurtuluş Ozdemir; Sibel Balci; Mehmet Akif Duzenli; Ilknur Can; Mehmet Yazici; Nazif Aygul; Bulent Behlul Altunkeser; Lutfullah Altintepe; Suleyman Turk
Journal:  Clin Cardiol       Date:  2007-07       Impact factor: 2.882

8.  Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model.

Authors:  Angelical S Martin; Dennis M Abraham; Kathleen A Hershberger; Dhaval P Bhatt; Lan Mao; Huaxia Cui; Juan Liu; Xiaojing Liu; Michael J Muehlbauer; Paul A Grimsrud; Jason W Locasale; R Mark Payne; Matthew D Hirschey
Journal:  JCI Insight       Date:  2017-07-20

9.  Hcc-1 is a novel component of the nuclear matrix with growth inhibitory function.

Authors:  C L Leaw; E C Ren; M L Choong
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

10.  Echocardiographic predictors of adverse clinical events in children with dilated cardiomyopathy: a prospective clinical study.

Authors:  C J McMahon; S F Nagueh; R S Eapen; W J Dreyer; I Finkelshtyn; X Cao; B W Eidem; L I Bezold; S W Denfield; J A Towbin; R H Pignatelli
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.